5th iPSC Drug Development Summit 2025

 

The 5th iPSC Drug Development Summit unites experts across R&D and CMC to accelerate genetically stable, scalable iPSC therapies. With two tailored tracks, Preclinical Development and Process Development & CMC, attendees will explore novel mouse models, bioreactors, and reprogramming methods.

Speakers from Novo Nordisk, BlueRock Therapeutics, Aspen Neuroscience, Sana Biotechnology, and more will share insights on immune evasion, GMP manufacturing, and regulatory strategy.

Covering oncology, neurology, and regenerative medicine, the agenda supports translation of early research into viable therapies. Connect with leading developers, regulators, and solution providers to drive your program forward.

Learn More And Secure Your Place. Continue Reading…

More Info

---

---